Edna Frances Roche

Edna Frances Roche

Auto-generated profile, based on publicly available information

Edna Frances Roche

The Discipline of Paediatrics, School of Medicine, Trinity College Dublin, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2018 in Diabetologia
Verified
Journal Article
Open access
PDF file
CPChristopher Patterson
Christopher Patterson
VHValma Harjutsalo
Valma Harjutsalo
JRJoachim Rosenbauer
Joachim Rosenbauer
ANAndreas Neu
Andreas Neu
OCOndrej Cinek
Ondrej Cinek
AGAnders Green
Anders Green
Aims/hypothesis Against a background of a near-universally increasing incidence of childhood type 1 diabetes, recent reports from some countries suggest a slowing in this increase. Occasional reports also describe cyclical variations in incidence, with periodicities of between 4 and 6 years. Methods Age/sex-standardised incidence rates for the 0- to 14-year-old age group are reported for 26 European centres (representing 22 countries) that have registered newly diagnosed individuals in geographically defined regions for up to 25 years during the period 1989–2013. Poisson regression was used to estimate rates of increase and test for cyclical patterns. Joinpoint regression software was used to fit segmented log-linear relationships to incidence trends. Results Significant increases in incidence were noted in all but two small centres, with a maximum rate of increase of 6.6% per annum in a Polish centre. Several centres in high-incidence countries showed reducing rates of increase in more recent years. Despite this, a pooled analysis across all centres revealed a 3.4% (95% CI 2.8%, 3.9%) per annum increase in incidence rate, although there was some suggestion of a reduced rate of increase in the 2004–2008 period. Rates of increase were similar in boys and girls in the 0- to 4-year-old age group (3.7% and 3.7% per annum, respectively) and in the 5- to 9-year-old age group (3.4% and 3.7% per annum, respectively), but were higher in boys than girls in the 10- to 14-year-old age group (3.3% and 2.6% per annum, respectively). Significant 4 year periodicity was detected in four centres, with three centres showing that the most recent peak in fitted rates occurred in 2012. Conclusions/interpretation Despite reductions in the rate of increase in some high-risk countries, the pooled estimate across centres continues to show a 3.4% increase per annum in incidence rate, suggesting a doubling in incidence rate within approximately 20 years in Europe. Although four centres showed support for a cyclical pattern of incidence with a 4 year periodicity, no plausible explanation for this can be given.

1 June 2005 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
EREdna Frances Roche
Edna Frances Roche
AMAnita Menon
Anita Menon
DGDenis Gill
Denis Gill
HHHilary Hoey
Hilary Hoey
To identify the presenting features of type 1 diabetes in a national incident cohort aged under 15 yr, the duration of symptoms, the occurrence of diabetic ketoacidosis (DKA) at presentation, and the frequency of a family history of diabetes. A prospective study was undertaken of incident cases of type 1 diabetes using an active monthly reporting card system from January 1, 1997 to December 31, 1998 in the Republic of Ireland. Follow-up questionnaires were distributed to pediatricians nationally. Two hundred and eighty-three incident cases were identified. Polyuria, polydipsia and weight loss were the main presenting symptoms in all age categories. Nocturnal enuresis was reported in 19% under 5 yr and in 31% aged 5-9.99 yr. Constipation was noted in five patients and in 10.4% under 5 yr of age. The median duration of symptoms was highest in the youngest (under 2 yr) and oldest (10-14.99 yr) age categories. Presentation in moderate/severe DKA occurred in 25% overall and six of nine of those aged under 2 yr. A family history of type 1 diabetes in a first-degree relative was found in 10.2%. This study confirms the abrupt onset of type 1 diabetes, the absence of a family history, and the importance of the classical symptoms of polyuria, polydipsia, and weight loss in the majority of cases. It reveals secondary enuresis as an important symptom, especially in those under 10 yr, and constipation in the under 5 yr age group. The very young (under 2 yr) are more difficult to diagnose, have more variability of symptom duration, and are more likely to present in moderate/severe DKA. A high index of suspicion aids early diagnosis.

17 April 2003 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
EREdna F. Roche
Edna F. Roche
Evangelia CharmandariEvangelia Charmandari
Evangelia Charmandari
MDMehul T. Dattani
Mehul T. Dattani
PHPeter Hindmarsh
Peter Hindmarsh

11 March 2009 in Diabetes Care
Verified
Journal Article
Open access
PDF file
SOStephen M.P. O'Riordan
Stephen M.P. O'Riordan
PHPeter Hindmarsh
Peter Hindmarsh
NHNathan R. Hill
Nathan R. Hill
DMDavid R. Matthews
David R. Matthews
SGSherly George
Sherly George
HHHilary Hoey
Hilary Hoey
OBJECTIVE To validate continuous glucose monitoring (CGM) in children and adolescents with cystic fibrosis. RESEARCH DESIGN AND METHODS Paired oral glucose tolerance tests (OGTTs) and CGM monitoring was undertaken in 102 children and adolescents with cystic fibrosis (age 9.5–19.0 years) at baseline (CGM1) and after 12 months (CGM2). CGM validity was assessed by reliability, reproducibility, and repeatability. RESULTS CGM was reliable with a Bland-Altman agreement between CGM and OGTT of 0.81 mmol/l (95% CI for bias ± 2.90 mmol/l) and good correlation between the two (r = 0.74–0.9; P < 0.01). CGM was reproducible with no significant differences in the coefficient of variation of the CGM assessment between visits and repeatable with a mean difference between CGM1 and CGM2 of 0.09 mmol/l (95% CI for difference ± 0.46 mmol/l) and a discriminant ratio of 13.0 and 15.1, respectively. CONCLUSIONS In this cohort of children and adolescents with cystic fibrosis, CGM performed on two occasions over a 12-month period was reliable, reproducible, and repeatable.

21 February 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SGSara Griffiths
Sara Griffiths
CLChey Loveday
Chey Loveday
AZAnna Zachariou
Anna Zachariou
LBLucy‐Ann Behan
Lucy‐Ann Behan
KCKate Chandler
Kate Chandler
KTKatrina Tatton‐Brown
Katrina Tatton‐Brown

22 September 2016 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
EREdna F. Roche
Edna F. Roche
AMAmanda M. McKenna
Amanda M. McKenna
KRKerry J Ryder
Kerry J Ryder
ABAdrienne A. Brennan
Adrienne A. Brennan
MOMyra O’regan
Myra O’regan
HHHilary Mcv Hoey
Hilary Mcv Hoey